Covid vaccination to be deferred by 3 months after recovery: Centre
If infected with Covid after 1st dose, 2nd dose to be deferred by 3 months after clinical recovery from Covid-19 illness, says Centre
Agencies Last Updated at May 19, 2021 21:02 IST
The Union Health Ministry on Wednesday announced that Covid vaccination should be deferred by three months after recovery from the illness and if infected after the first dose, the second dose should be deferred by three months after clinical recovery from illness.
Accepting the recommendation of the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), the Union Health Ministry said, “The NEGVAC has shared fresh recommendations regarding Covid vaccination with the Ministry. These recommendations have been based on the evolving situation of the Covid-19 pandemic and emerging global scientific evidence and experience. The ministry has accepted these recommendations and has communicated to the states and UTs.”
The new guidelines say that in individuals having lab tests proven Covid-19 illness, the vaccination must be deferred by three months after recovery.
Vaccination of Covid patients who have been given anti-SARS-2 monoclonal antibodies or convalescent plasma by three months from the date of discharge from the hospital, individuals who have received at least the first dose and got Covid-19 infection before completion of the dosing schedule, the second dose should be deferred by three months after clinical recovery from Covid-19 illness.
Persons with any other serious general illness requiring hospitalisation or ICU care should also wait for four to eight weeks before getting the vaccine. An individual can donate blood after 14 days of either receipt of Covid vaccine or testing RT-PCR negative, if suffering from Covid-19 disease.
Covid vaccination is recommended for all lactating women and there is no requirement for screening of the vaccine recipients by rapid antigen test (RAT) prior to Covid vaccination.
“Regarding Covid vaccination of pregnant women, the matter is under discussion and further deliberation by the National Technical Advisory Group on Immunisation (NTAGI),” the Ministry said.
The Union Health Ministry has written to states and UTs to direct the concerned officials to take note of these recommendations and undertake necessary action for their effective implementation.
“States have been advised to ensure effective dissemination of the information to service providers as well as the general public, through use of all channels of information and communication in the local languages. States have also been advised to undertake training of the vaccination staff at all levels,” the ministry said.
The cumulative number of Covid vaccine doses administered in the country has reached nearly 186 million.
A total of 18,58,09,302 vaccine doses have been administered through 27,10,934 sessions, as per the provisional report till 7 am on Wednesday.
These include 96,73,684 healthcare workers (HCWs) who have taken the first dose and 66,59,125 HCWs who have taken the second dose; 1,45,69,669 frontline workers (FLWs) who have received the first dose, 82,36,515 FLWs who have taken the second dose and 64,77,443 beneficiaries in the 18-44 years age group who have received the first dose.
Besides, 5,80,46,339 and 93,51,036 beneficiaries aged 45 to 60 have been administered the first and second dose, respectively, while 5,48,16,767 and 1,79,78,724 beneficiaries above 60 years old have taken the first and second dose, respectively.
India’s total COVID-19 active cases has decreased to 32,26,719 with a decline of 1,27,046 being recorded in the active case count in a day. It now comprises 12.66 per cent of the country’s total cases.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.